Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers
Abstract Data about the duration of humoral response following COVID-19 vaccines are mandatory to establish appropriate population vaccination strategy. This study reports on the antibody decline observed in a population of COVID-19 naïve and COVID-19 positive individuals having received the two dose regimen of the BNT162b2 vaccine. Six months after vaccination, a significant antibody decline was observed in both COVID-19 naïve and positive individuals. The estimated half-life of total and IgG antibodies differs and ranges from several months for total antibodies to only several weeks for IgG antibodies, explaining the significant proportions of participants with non-detectable levels of neutralizing antibodies at 6 months. Whether this decrease correlates with an equivalent drop in the clinical effectiveness against the virus will require appropriate clinical studies. Nevertheless, these data are already important to support the decision-making on the potential use of a booster dose..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
ResearchSquare.com - (2021) vom: 03. Sept. Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bayart, Jean-Louis [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
doi: |
10.21203/rs.3.rs-862966/v1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XRA033444773 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XRA033444773 | ||
003 | DE-627 | ||
005 | 20230429182821.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220113s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21203/rs.3.rs-862966/v1 |2 doi | |
035 | |a (DE-627)XRA033444773 | ||
035 | |a (ResearchSquare)10.21203/rs.3.rs-862966/v1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 570 |q DE-84 | |
100 | 1 | |a Bayart, Jean-Louis |e verfasserin |4 aut | |
245 | 1 | 0 | |a Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Data about the duration of humoral response following COVID-19 vaccines are mandatory to establish appropriate population vaccination strategy. This study reports on the antibody decline observed in a population of COVID-19 naïve and COVID-19 positive individuals having received the two dose regimen of the BNT162b2 vaccine. Six months after vaccination, a significant antibody decline was observed in both COVID-19 naïve and positive individuals. The estimated half-life of total and IgG antibodies differs and ranges from several months for total antibodies to only several weeks for IgG antibodies, explaining the significant proportions of participants with non-detectable levels of neutralizing antibodies at 6 months. Whether this decrease correlates with an equivalent drop in the clinical effectiveness against the virus will require appropriate clinical studies. Nevertheless, these data are already important to support the decision-making on the potential use of a booster dose. | ||
700 | 1 | |a Douxfils, Jonathan |e verfasserin |4 aut | |
700 | 1 | |a Gillot, Constant |e verfasserin |4 aut | |
700 | 1 | |a David, Clara |e verfasserin |4 aut | |
700 | 1 | |a Mullier, François |e verfasserin |4 aut | |
700 | 1 | |a Elsen, Marc |e verfasserin |4 aut | |
700 | 1 | |a Eucher, Christine |e verfasserin |4 aut | |
700 | 1 | |a Eeckhoudt, Sandrine Van |e verfasserin |4 aut | |
700 | 1 | |a Roy, Tatiana |e verfasserin |4 aut | |
700 | 1 | |a Gerin, Vincent |e verfasserin |4 aut | |
700 | 1 | |a Wieers, Grégoire |e verfasserin |4 aut | |
700 | 1 | |a Laurent, Christine |e verfasserin |4 aut | |
700 | 1 | |a Closset, Mélanie |e verfasserin |4 aut | |
700 | 1 | |a Dogné, Jean-Michel |e verfasserin |4 aut | |
700 | 1 | |a Favresse, Julien |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2021) vom: 03. Sept. |
773 | 1 | 8 | |g year:2021 |g day:03 |g month:09 |
856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-862966/v1 |z kostenfrei |3 Volltext |
912 | |a GBV_XRA | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2021 |b 03 |c 09 | ||
953 | |2 045F |a 570 |